ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA)

Historical Holders from Q2 2014 to Q3 2025

Symbol
ADMA on Nasdaq
CUSIP
000899104
Type / Class
Equity / COMMON STOCK
Shares outstanding
237M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
211M
Holdings value
$3.84B
% of all portfolios
0.006%
Grand Portfolio weight change
+0%
Number of holders
367
Number of buys
230
Number of sells
-161
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.1% $726M 35.9M BlackRock, Inc. Mar 31, 2025
VANGUARD GROUP INC 8.94% $453M 21.4M The Vanguard Group Jun 30, 2025
Invesco Ltd. 5.4% +12% $260M $31.8M 12.9M +13.9% Invesco Ltd. Mar 31, 2025
STATE STREET CORP 5.1% +6% $256M $13.5M 12.1M +5.57% STATE STREET CORPORATION Jun 30, 2025

Institutional Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 16K $296K -$2.19M $14.66 5
2025 Q2 211M $3.84B +$78.9M $18.21 367
2025 Q1 205M $4.07B +$76.5M $19.84 341
2024 Q4 204M $3.5B -$114M $17.15 316
2024 Q3 207M $4.14B +$165M $19.99 302
2024 Q2 181M $2.02B +$85.8M $11.18 250
2024 Q1 174M $1.15B +$38.7M $6.60 212
2023 Q4 340K $1.54M -$25.6K $4.52 2
2023 Q3 170M $610M +$19.9M $3.58 186
2023 Q2 165M $608M +$1.96M $3.69 176
2023 Q1 165M $545M +$39M $3.31 159
2022 Q4 152M $590M +$83.7M $3.88 157
2022 Q3 130M $315M +$25.7M $2.43 125
2022 Q2 119M $236M +$30.4M $1.98 106
2022 Q1 105M $190M +$15.2M $1.83 101
2021 Q4 96.9M $137M +$70.1M $1.41 76
2021 Q3 41.8M $47.3M -$1.97M $1.13 65
2021 Q2 42.4M $67.8M -$9.38M $1.60 81
2021 Q1 48.5M $85.3M +$4.46M $1.76 99
2020 Q4 45.1M $88M -$3.26M $1.95 88
2020 Q3 42.6M $102M -$6.94M $2.39 88
2020 Q2 48.8M $143M +$1.12M $2.93 94
2020 Q1 48.3M $139M +$45M $2.88 89
2019 Q4 32.4M $130M -$5.59M $4.00 71
2019 Q3 37.1M $165M +$9.87M $4.45 68
2019 Q2 35M $135M +$49.5M $3.87 62
2019 Q1 22.3M $84.5M -$8.22M $3.79 53
2018 Q4 24.7M $58M -$3.61M $2.39 46
2018 Q3 26.6M $165M +$8.8M $6.21 54
2018 Q2 25.5M $115M +$41.3M $4.51 50
2018 Q1 17M $78M -$211K $4.60 34
2017 Q4 17M $54.7M +$27.5M $3.21 23
2017 Q3 8.45M $26M -$2.12M $3.08 17
2017 Q2 8.91M $33.2M -$1.18M $3.70 19
2017 Q1 9.23M $45M -$611K $4.88 17
2016 Q4 9.37M $48M -$551K $5.12 17
2016 Q3 9.48M $68.7M +$189K $7.24 18
2016 Q2 9.52M $57.4M +$6.74M $5.95 27
2016 Q1 8.27M $66.9M -$1.02M $8.09 20
2015 Q4 8.42M $68M -$509K $8.07 24
2015 Q3 7.05M $58.9M +$163K $8.36 22
2015 Q2 3.42M $31.7M +$721K $9.26 22
2015 Q1 3.34M $32.7M +$9.2M $9.80 17
2014 Q4 2.37M $26.4M +$14.3M $11.17 11
2014 Q3 777K $8M +$1.13M $10.30 1
2014 Q2 667K $6.5M +$6.5M $9.75 1